Proton Chemical Shift Imaging in Pick Complex

References

1. ↵
   Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 1976;2:1403

   PubMedWeb of Science
2. ↵
   Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosurg Psychiatry 1999;67:558

   FREE Full Text
3. ↵
   Murayama S, Mori H, Ihara Y, Tomonaga M. Immunocytochemical and ultrastructural studies of Pick’s disease. Ann Neurol 1990;27:394–405

   CrossRefPubMedWeb of Science
4. ↵
   Hulette CM, Crain BJ. Lobar atrophy without Pick bodies. Clin Neuropathol 1992;11:151–156

   PubMedWeb of Science
5. ↵
   Constantinidis J, Richard J, Tissot R. Pick’s disease: histological and clinical correlations. Eur Neurol 1974;11:208–217

   PubMedWeb of Science
6. ↵
   Dickson DW. Neuropathology of Pick’s disease. Neurology 2001;56:16–20
7. ↵
   Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171–1192

   Abstract/FREE Full Text
8. ↵
   The Lund and Manchester Groups. Consensus Statement. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416–418

   FREE Full Text
9. ↵
   Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982;11:592–598

   CrossRefPubMedWeb of Science
10. ↵
    Kertesz A, Hudson L, Mackenzie IR, Munoz DG. The pathology and nosology of primary progressive aphasia. Neurology 1994;44:2065–2072

    Abstract/FREE Full Text
11. Lang AE, Bergeron C, Pollanen MS, Ashby P. Parietal Pick’s disease mimicking cortical-basal ganglionic degeneration. Neurology 1994;44:1436–1440

    Abstract/FREE Full Text
12. Fukui T, Sugita K, Kawamura M, Shiota J, Nakano I. Primary progressive apraxia in Pick’s disease: a clinicopathologic study. Neurology 1996;47:467–473

    Abstract/FREE Full Text
13. Kertesz A, Martinez-Lage P, Davidson W, Munoz DG. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000;55:1368–1375

    Abstract/FREE Full Text
14. ↵
    Mimura M, Oda T, Tsuchiya K, et al. Corticobasal degeneration presenting with nonfluent primary progressive aphasia: a clinicopathological study. J Neurol Sci 2001;183:19–26

    CrossRefPubMedWeb of Science
15. ↵
    Kertesz A, Munoz D. Pick’s disease, frontotemporal dementia, and Pick complex: emerging concepts. Arch Neurol 1998;55:302–304

    CrossRefPubMedWeb of Science
16. ↵
    Frisoni GB, Beltramello A, Geroldi C, Weiss C, Bianchetti A, Trabucchi M. Brain atrophy in frontotemporal dementia. J Neurol Neurosurg Psychiatry 1996;61:157–165

    Abstract/FREE Full Text
17. ↵
    Kitagaki H, Mori E, Yamaji S, et al. Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. Radiology 1998;208:431–439

    PubMedWeb of Science
18. ↵
    Tokumaru AM, O’uchi T, Kuru Y, Maki T, Murayama S, Horichi Y. Corticobasal degeneration: MR with histopathologic comparison. AJNR Am J Neuroradiol 1996;17:1849–1852

    Abstract
19. ↵
    Sinnatamby R, Antoun NA, Freer CE, Miles KA, Hodges JR. Neuroradiological findings in primary progressive aphasia: CT MRI and cerebral perfusion SPECT. Neuroradiology 1996;38:232–238

    PubMedWeb of Science
20. ↵
    Abe K, Ukita H, Yanagihara T. Imaging in primary progressive aphasia. Neuroradiology 1997;39:556–559

    CrossRefPubMedWeb of Science
21. ↵
    Ishii K, Sakamoto S, Sasaki M, et al. Cerebral glucose metabolism inpatients with frontotemporal dementia. J Nucl Med 1998;39:1875–1878

    Abstract/FREE Full Text
22. ↵
    Nagahama Y, Fukuyama H, Turjanski N, et al. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls. Mov Disord 1997;12:691–696

    CrossRefPubMedWeb of Science
23. ↵
    Chawluk JB, Mesulam MM, Hurtig H, et al. Slowly progressive aphasia without generalized dementia: studies with positron emission tomography. Ann Neurol 1986;19:68–74

    CrossRefPubMedWeb of Science
24. ↵
    Luyten PR, Marien AJ, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990;176:791–799

    PubMedWeb of Science
25. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675–686

    PubMed
26. ↵
    Constans JM, Meyerhoff DJ, Gerson J, et al. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. Radiology 1995;197:517–523

    PubMedWeb of Science
27. ↵
    Smith CD, Gallenstein LG, Layton WJ, Kryscio RJ, Markesbery WR. 31P magnetic resonance spectroscopy in Alzheimer’s and Pick’s disease. Neurobiol Aging 1993;14:85–92

    CrossRefPubMedWeb of Science
28. ↵
    Ernst T, Chang L, Melchor R, Mehringer CM. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 1997;203:829–836

    PubMedWeb of Science
29. ↵
    Tedeschi G, Litvan I, Bonavita S, et al. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson’s disease and corticobasal degeneration. Brain 1997;120:1541–1552

    Abstract/FREE Full Text
30. ↵
    Abe K, Terakawa H, Takanashi M, et al. Proton magnetic resonance spectroscopy of patients with parkinsonism. Brain Res Bull 2000;52:589–595

    CrossRefPubMedWeb of Science
31. ↵
    Moore CM, Frederick BB, Renshaw PF. Brain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly. J Geriatr Psychiatry Neurol 1999;12:107–117